SCHEMBL23459119

SCHEMBL23459119

COc1ccc(CC2CCCN2C(=O)C(F)(F)F)cc1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.55
ABHD6 Q9BV23 1/20 0.51
DAGLA Q9Y4D2 1/20 0.51
HRH3 Q9Y5N1 2/20 0.50
HCRTR1 O43613 3/20 0.48
HCRTR2 O43614 3/20 0.48
FFAR1 O14842 1/20 0.46
DPP4 P27487 1/20 0.45
FAP Q12884 1/20 0.45
DPP8 Q6V1X1 1/20 0.45
DPP9 Q86TI2 1/20 0.45
DPP7 Q9UHL4 1/20 0.45
GAA P10253 1/20 0.44
HPGD P15428 1/20 0.44
ALDH1A1 P00352 2/20 0.43
FKBP1A P62942 1/20 0.42
TSHR P16473 1/20 0.42
KMT2A Q03164 1/20 0.42
DAGLB Q8NCG7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14417553 1.00 HSD11B1 (0.55) HSD11B1ABHD6DAGLAHRH3HCRTR1
SCHEMBL23477764 0.95 ABHD6 (0.54) HSD11B1ABHD6DAGLAHRH3HCRTR1
SCHEMBL23459022 0.86 ABHD6 (0.54) HSD11B1ABHD6DAGLAHRH3HCRTR1
SCHEMBL23459012 0.84 ATM (0.48) HSD11B1ABHD6DAGLAHRH3HCRTR1
SCHEMBL23459010 0.84 ATM (0.48) HSD11B1ABHD6DAGLAHRH3HCRTR1
SCHEMBL7379928 0.84 HCRTR1 (0.57) HSD11B1HCRTR1HCRTR2
SCHEMBL7381768 0.84 HCRTR1 (0.57) HSD11B1HCRTR1HCRTR2
SCHEMBL7379923 0.84 HCRTR1 (0.57) HSD11B1HCRTR1HCRTR2
SCHEMBL30360947 0.84 HRH3 (0.54) ABHD6DAGLAHRH3HCRTR1HCRTR2
SCHEMBL23477958 0.84 ESR1 (0.41) HSD11B1ABHD6DAGLAHRH3DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4069366-B1 ATM KINASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF CHDI FOUNDATION INC (US) 2025-03-19 EP disclosed
US-11685734-B2 ATM kinase inhibitors and compositions and methods of use thereof CHDI FOUNDATION, INC. (US) 2023-06-27 US disclosed
US-11685734-B2 ATM kinase inhibitors and compositions and methods of use thereof CHDI FOUNDATION, INC. (US) 2023-06-27 US disclosed
EP-4069366-A1 ATM KINASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF CHDI Foundation, Inc. (US) 2022-10-12 EP disclosed
US-20210188827-A1 ATM KINASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF CHDI FOUNDATION, INC. 2021-06-24 US disclosed
US-20210188827-A1 ATM KINASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF CHDI FOUNDATION, INC. 2021-06-24 US disclosed
WO-2021113506-A1 ATM KINASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF CHDI FOUNDATION, INC. (US) 2021-06-10 WO disclosed
WO-2021113506-A1 ATM KINASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF CHDI FOUNDATION, INC. (US) 2021-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11685734-B2 ATM kinase inhibitors and compositions and methods of use thereof ATM, CHEK2, CHEK1 HSD11B1 2993/4885ABHD6 3275/4885DAGLA 3969/4885
US-20210188827-A1 ATM KINASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF ATM, CHEK2, CHEK1 HSD11B1 2993/4885ABHD6 3275/4885DAGLA 3969/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.